FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for LYRICA (pregabalin) filed by Parke-Davis Div of Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Epilepsy
• Fibromyalgia
• Postherpetic Neuralgia

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

SUPPL AP for LYRICA (PREGABALIN)